Fact: Stopping GLP-1 medications suddenly may contribute to increased appetite and rapid weight regain, so its important to work with a healthcare provider on a transition plan
Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity 2024 Available from: Ruggiero R, Mascolo A, Spezzaferri A, Carpentieri C, Torella D, Sportiello L, et al
Cureus , doi: 10.7759/cureus.77998 (2025)
This requires urgent medical assessment
These trials, including STEP-1 through STEP-6, highlighted semaglutides superiority over placebo and other treatments, such as liraglutide, in promoting weight loss and enhancing cardiometabolic parameters, including blood pressure and lipid profiles [6][15]
Further studies may reveal is other medications like topical or oral metformin can have benefit as well